Skip to main content

Table 2 Baseline comparisons of cardiometabolic risk indicators between patients and controls

From: Cardiometabolic risk indicators in individuals with bipolar disorders: a replication study

CMRIs

Patients (n = 407)

Controls (n = 56)

T-test

Linear regression

(adjusted for age and sex)

Mean difference (95% CI)

P-value

Coefficient estimate

P-value

WHR, mean ± SD

0.88 ± 0.08

0.89 ± 0.07

− 0.01 (− 0.03–0.01)

0.2

0.003

> 0.30

BMI, mean ± SD, kg/m2

26.9 ± 5.9

24.9 ± 3.6

2.1 (0.9–3.2)

< 0.001

0.14

0.003

SBP, mean ± SD, mm Hg

124.2 ± 14.4

126.2 ± 10.3

− 1.9 (− 5.1–1.1)

0.2

− 0.003

> 0.30

DBP, mean ± SD, mm Hg

76.8 ± 9.3

80.3 ± 8.7

− 3.4 (− 6.0 – − 0.9)

0.009

− 0.09

0.05

TAG, mean ± SD, mmol/L

1.1 ± 0.9

1.0 ± 0.5

0.1 (− 0.1–0.3)

0.2

0.06

0.2

TAG/HDL-C ratio, mean ± SD

0.9 ± 1.5

0.7 ± 0.6

0.2 (− 0.2–0.6)

> 0.30

0.06

0.2

TChol/HDL-C ratio, mean ± SD

3.6 ± 2.1

3.5 ± 1.5

0.2 (− 0.4–0.7)

> 0.30

0.04

> 0.30

Non-HDL-C, mean ± SD, mmol/L

3.5 ± 1.0

3.6 ± 1.0

− 0.1 (− 0.4–0.2)

> 0.30

− 0.005

> 0.30

  1. Note
  2. Comparisons are made using multiply imputed data.
  3. Abbreviations: BMI, body mass index; CI, confidence interval; CMRIs, cardiometabolic risk indicators; DBP, diastolic blood pressure; HDL-C, plasma high-density lipoprotein-cholesterol; SBP, systolic blood pressure; SD, standard deviation; TAG, fasting plasma triacylglycerol; TChol, total plasma cholesterol; WHR, waist-to-hip ratio.